Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Franklin Strategic Series - Franklin Biotechnology Discovery Fund

+ Add to Watchlist

FBDIX:US

176.35 USD 4.14 2.29%

As of 09:29:30 ET on 01/28/2015.

Snapshot for Franklin Strategic Series - Franklin Biotechnology Discovery Fund (FBDIX)

Year To Date: +4.62% 3-Month: +9.15% 3-Year: +39.43% 52-Week Range: 118.65 - 180.49
1-Month: +3.93% 1-Year: +26.74% 5-Year: +30.60% Beta vs SPX: 1.05

Mutual Fund Chart for FBDIX

No chart data available.
  • FBDIX:US 176.35
  • 1M
  • 1Y
Interactive FBDIX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBDIX

Franklin Biotechnology Discovery Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The Fund invests a substantial portion of its assets in equity securities of smaller capitalization companies.

Inception Date: 09-15-1997 Telephone: (800) 632-2350
Managers: EVAN MCCULLOCH / JEREL BANKS
Web Site: www.franklintempleton.com

Fundamentals for FBDIX

NAV (on 2015-01-28) 176.35
Assets (M) (on 2014-12-31) 1,707.06
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment -

Dividends for FBDIX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-12-15) 3.73
Dividend Yield (ttm) 3.78

Fees & Expenses for FBDIX

Front Load 5.75
Back Load 0.00
Current Mgmt Fee 0.59
Redemption Fee 0.00
12b1 Fee 0.30
Expense Ratio 1.10

Top Fund Holdings for FBDIX

Filing Date: 12/31/2014
Name Position Value % of Total
Celgene Corp 1,509,100 168,807,926 9.789%
Biogen Idec Inc 368,261 125,006,196 7.249%
Gilead Sciences Inc 1,188,500 112,028,010 6.497%
Amgen Inc 562,600 89,616,554 5.197%
Medivation Inc 592,454 59,014,343 3.422%
Regeneron Pharmaceuticals Inc 132,209 54,238,742 3.145%
Illumina Inc 276,100 50,962,538 2.955%
BioMarin Pharmaceutical Inc 560,384 50,658,714 2.938%
Incyte Corp 678,100 49,575,891 2.875%
Alexion Pharmaceuticals Inc 226,600 41,927,798 2.431%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil